Study on the Value of Multi-b-value DWI and T2 Mapping Quantitative Techniques in the Diagnosis of Prostate Cancer and Benign Prostatic Hyperplasia Nodules
Wang Xu1, Chen Ting1, Wang Shan1, Xie Xiaoping2
1. Department of Radiology,Jiangyin Hospital affiliated to Nantong University,Jiangyin,Jiangsu 214400; 2. Department of Radiology,63680 PLA Army Hospital,Jiangyin,Jiangsu 214400
Abstract：Objective To investigate the diagnostic value of multi-b-value diffusion-weighted imaging(DWI)and T2 mapping quantitative parameters in differentiating prostate cancer(PCa)from benign prostatic hyperplasia(BPH). Materials and Methods A retrospective analysis was conducted on imaging data from 67 pathologically confirmed PCa patients and 66 BPH patients who underwent MR examination in our hospital.ADC values from DWI at b=1000 and 2000 s/mm2 and T2 mapping values were measured in both groups.Differences in ADC values at different b-values and T2 values between the two groups were compared. Results Operating characteristic(ROC)curve analysis was used to evaluate the diagnostic performance of each parameter and the combined ADC2000-T2 model. Results The ADC1000,ADC2000,and T2 values in the PCa group were significantly lower than those in the BPH group,with statistically significant differences(P<0.01).The AUC values for differentiating PCa from BPH were 0.80 for ADC1000,0.83 for ADC2000,0.89 for T2 value,and 0.92 for the combined ADC2000-T2 model.The diagnostic performance of the combined ADC2000-T2 mapping model was superior to that of ADC1000 or ADC2000 alone,and the difference was statistically significant. Conclusion Quantitative parameters from DWI and T2 mapping sequences demonstrate good diagnostic value in differentiating PCa from BPH.Moreover,the combined model incorporating high b-value DWI and T2 mapping further improves diagnostic performance,providing a reliable basis for the clinical diagnosis of PCa.
王旭, 陈婷, 王姗, 谢晓平. 多b值DWI与T2 mapping定量技术诊断前列腺癌与前列腺增生结节价值研究[J]. 哈尔滨医药, 2026, 46(1): 4-7.
Wang Xu, Chen Ting, Wang Shan, Xie Xiaoping. Study on the Value of Multi-b-value DWI and T2 Mapping Quantitative Techniques in the Diagnosis of Prostate Cancer and Benign Prostatic Hyperplasia Nodules. journal1, 2026, 46(1): 4-7.
[1] RAWLA P.Epidemiology of prostate cancer[J].World J Oncol,2019,10(2):63-89. [2] 陈维娟,赵飞,李新红,等.基于双参数磁共振成像的PI-RADS v2.1评分联合PSAD对移行带前列腺癌的诊断价值[J].磁共振成像,2025,16(08):95-99+105. [3] 邓晓俊,张皓诚,张炯,等.PI-RADS v2.1对外周带、移行带及多区域前列腺临床显著癌的诊断性能研究[J].中华男科学杂志,2024,30(11):982-986. [4] Scott R,Misser SK,Cioni D,et al.PI-RADS v2.1:What has changed and how to report.SA [J] Raddiol.2021,25(1):2062. [5] MAZZONI L N,LUCARINI S,CHITI S,et al.Diffusion-weighted signal models in healthy and cancerous peri-pheral prostate tissues:comparison of outcomes obtained at different b-values[J].J Magn Reson Imaging,2014,39(3):512-518. [6] 康立丽,路世龙,胡志,等.MR图像T2定量分析的单指数、多指数方法分析与探讨[J].实用放射学杂志,2012,28(5):763-766. [7] 李新瑜,刘晴晴,李明霞,等.高b值表观扩散系数与动态增强磁共振定量参数对移行带前列腺癌的诊断价值[J].中国医学影像学杂志,2023,31(10):1096-1100+1108. [8] 俞立琛,刘哲南,万晓晓.3.0T常规MRI联合多b值DWI在前列腺癌诊断中的应用价值[J].影像研究与医学应用,2025,9(17):133-135. [9] White NS,Dale AM.Distinct effects of nuclear volume fraction and cell diameter on high b-value diffusion MRI contrast in tumors[J].Magn Reson Med,2014,7(2):1435-1443. [10] 崔强,王凡,程华才,等.不同b值ADC对前列腺癌患者术后Gleason评分的预测效果[J].中南医学科学杂志,2024,52(04):669-672. [11] 王旭,孟宪平,费锋,等.高b值磁共振弥散加权成像诊断前列腺癌的临床价值[J].医学影像学杂志,2017,27(12):2354-2356. [12] 胡文君,刘爱连,陈丽华,等.酰胺质子转移成像联合T2-mapping鉴别前列腺癌与前列腺增生的价值[J].放射学实践,2022,37(11):1416-1421. [13] 朱柳红,刘豪,周建军.磁共振T2 mapping技术在体部恶性肿瘤中的研究进展[J].磁共振成像,2020,11(05):398-400. [14] Yamauchi FI,Penzkofer T,Fedorov A,et al.Prostate cancer discrimination in the peripheral zone with a reduced field-of-view T2-mapping MRI sequence.Magn Reson Imaging,2015,33(5):525-530. [15] 梁结宜,王宇泽,雷强,等.T2值对中央腺体前列腺癌与前列腺增生诊断价值的初步探讨[J].实用放射学杂志,2019,35(09):1464-1467. [16] 朱旭,马翼,潘昌杰.T2mapping与T2*mapping定量值在前列腺病变中的诊断价值[J].大连医科大学学报,2021,43(05):438-441. [17] 李茜玮,陈丽华,王楠,等.DWI联合T2 mapping序列鉴别前列腺癌与前列腺增生价值评估[J].磁共振成像,2024,15(02):97-102.
2026, Vol. 46 
